Stefan Schwarz Selected Research

Glycyrrhetinic Acid (Po 12)

1/2014	A "natural" approach: synthesis and cytoxicity of monodesmosidic glycyrrhetinic acid glycosides.
3/2012	Conversions at C-30 of glycyrrhetinic acid and their impact on antitumor activity.
1/2012	Does one keto group matter? Structure-activity relationships of glycyrrhetinic acid derivatives modified at position C-11.
8/2011	Improvement of the cytotoxicity and tumor selectivity of glycyrrhetinic acid by derivatization with bifunctional amino acids.
12/2010	Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan Schwarz Research Topics

Disease

38	Infections 01/2022 - 08/2002
12	Neoplasms (Cancer) 03/2017 - 10/2009
11	Bovine Mastitis 12/2019 - 05/2006
9	Mastitis 10/2017 - 05/2006
7	Stroke (Strokes) 10/2016 - 01/2002
5	Lung Diseases (Lung Disease) 01/2022 - 04/2003
5	Bacterial Infections (Bacterial Infection) 06/2020 - 09/2003
5	Respiratory Tract Infections (Respiratory Tract Infection) 09/2007 - 08/2003
4	Septic Shock (Toxic Shock Syndrome) 09/2020 - 10/2011
3	Primary Graft Dysfunction 01/2021 - 01/2019
3	Dementia (Dementias) 10/2015 - 11/2008
3	Hypertension (High Blood Pressure) 09/2015 - 02/2015
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 02/2022 - 01/2022
2	Wounds and Injuries (Trauma) 01/2022 - 01/2021
2	Pulmonary Hypertension 03/2021 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 03/2017 - 01/2017
2	Pneumonia (Pneumonitis) 10/2016 - 04/2003
2	Pathologic Constriction (Stenosis) 04/2016 - 04/2003
2	Alzheimer Disease (Alzheimer's Disease) 10/2015 - 11/2012
2	Ischemic Stroke 01/2009 - 04/2008
1	Psychotic Disorders (Schizoaffective Disorder) 03/2022
1	Multiple Trauma (Multiple Injuries) 01/2022
1	Emphysema 01/2022
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022
1	Intraabdominal Infections 12/2021
1	Lung Neoplasms (Lung Cancer) 03/2021
1	Inflammation (Inflammations) 03/2021
1	Renal Insufficiency (Renal Failure) 01/2021
1	Congenital Abnormalities (Deformity) 01/2021
1	Funnel Chest (Pectus Excavatum) 01/2021
1	Aneurysm (Aneurysms) 01/2020
1	Bronchiolitis 01/2019
1	Meningitis 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Cystic Fibrosis (Mucoviscidosis) 08/2018
1	Overweight 08/2018
1	Soft Tissue Infections 01/2018
1	Neoplasm Metastasis (Metastasis) 03/2017

Drug/Important Bio-Agent (IBA)

19	Anti-Infective Agents (Microbicides)IBA 01/2022 - 09/2003
12	Anti-Bacterial Agents (Antibiotics)IBA 12/2021 - 08/2002
8	CoagulaseIBA 06/2015 - 05/2006
5	Linezolid (Zyvox)FDA Link 01/2022 - 01/2013
5	MacrolidesIBA 10/2016 - 05/2006
5	Glycyrrhetinic Acid (Po 12)IBA 01/2014 - 12/2010
4	Pharmaceutical PreparationsIBA 01/2020 - 10/2014
4	AgarIBA 02/2017 - 08/2003
3	DNA (Deoxyribonucleic Acid)IBA 05/2018 - 04/2010
3	Cefoperazone (Cefoperazone Sodium)FDA Link 02/2017 - 05/2012
3	TylosinIBA 10/2016 - 01/2007
3	lissamine rhodamine B (sulforhodamine B)IBA 08/2015 - 10/2009
3	Methicillin (Metin)FDA Link 08/2012 - 02/2009
2	CytokinesIBA 01/2022 - 03/2021
2	Prostaglandins DIBA 01/2021 - 07/2020
2	Leukocidins (Leukocidin)IBA 09/2020 - 12/2019
2	Oxygen (Dioxygen)IBA 06/2020 - 12/2015
2	Colistin (Coly-Mycin)FDA Link 01/2020 - 01/2016
2	Panton-Valentine leukocidinIBA 12/2019 - 10/2011
2	Virulence Factors (Pathogenicity Factors)IBA 12/2019 - 10/2011
2	Antimicrobial PeptidesIBA 01/2019 - 10/2017
2	CathelicidinsIBA 01/2019 - 10/2017
2	Third Generation CephalosporinsIBA 02/2017 - 07/2014
2	florfenicolIBA 12/2016 - 08/2003
2	Erythromycin (Erycette)FDA LinkGeneric 10/2016 - 07/2014
2	Antihypertensive Agents (Antihypertensives)IBA 09/2015 - 02/2015
2	Betulinic AcidIBA 01/2014 - 08/2011
2	AcidsIBA 01/2012 - 08/2011
2	Oxacillin (Prostaphlin)FDA LinkGeneric 08/2010 - 02/2008
2	pirlimycinIBA 01/2007 - 05/2006
1	N 30IBA 03/2022
1	Tigecycline (Tygacil)FDA Link 12/2021
1	Calcineurin InhibitorsIBA 01/2021
1	Carbon DioxideIBA 01/2021
1	carbapenemaseIBA 01/2020
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2020
1	Staphylococcal enterotoxin FIBA 12/2019
1	Disinfectants (Biocides)IBA 12/2019
1	Alemtuzumab (Campath)FDA Link 01/2019
1	Antimicrobial Cationic PeptidesIBA 01/2019
1	prednylidene (Pred)IBA 08/2018
1	BMAP-28IBA 10/2017
1	BMAP-27IBA 10/2017
1	Dinoprostone (PGE2)FDA Link 03/2017
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2017
1	LactamsIBA 02/2017
1	5'-N-methylcarboxamideadenosineIBA 02/2017

Therapy/Procedure

12	Lung Transplantation 02/2022 - 01/2017
10	Therapeutics 01/2022 - 01/2002
4	Transplantation 01/2022 - 01/2019
3	Denervation 09/2015 - 02/2015
2	Metastasectomy 03/2017 - 01/2017
2	Antibiotic Prophylaxis 01/2016 - 04/2008
2	Complementary Therapies (Alternative Medicine) 11/2008 - 03/2008
1	Organ Transplantation 01/2022
1	Pneumonectomy (Lung Volume Reduction) 01/2022
1	Extracorporeal Circulation 03/2021
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 03/2021
1	Extracorporeal Membrane Oxygenation 03/2021
1	Endarterectomy (Thromboendarterectomy) 03/2021
1	Contraindications 01/2021
1	Operative Surgical Procedures 10/2020